Patton Fund Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,622
Closed -$290K 143
2026
Q1
$290K Buy
4,622
+2,343
+103% +$187K 0.05% 184
2025
Q4
$217K Buy
2,279
+118
+5% +$11.6K 0.03% 408
2025
Q3
$211K Hold
2,161
0.04% 416
2025
Q2
$232K Buy
+2,161
New +$219K 0.05% 297
2023
Q1
Sell
-4,652
Closed -$215K 104
2022
Q4
$215K Buy
+4,652
New +$201K 0.06% 116
2019
Q4
Sell
-76,461
Closed -$3.11M 83
2019
Q3
$3.11M Buy
76,461
+29,165
+62% +$1.24M 1.24% 28
2019
Q2
$2.03M Buy
+47,296
New +$1.82M 0.81% 52

Other funds holding BSX

Patton Fund Management's BSX Position: Q2 2026 in Review

Patton Fund Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,622 shares — an estimated $290K sold.

Patton Fund Management first reported a position in BSX in Q2 2019 and held it in 7 quarters. The position peaked at $3.11M in Q3 2019. 241 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Patton Fund Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Patton Fund Management sold 4,622 Boston Scientific shares in Q2 2026, an estimated $290K.
  • Patton Fund Management first reported a position in Boston Scientific in Q2 2019 and held it in 7 quarters.
  • Patton Fund Management's Boston Scientific position peaked at $3.11M in Q3 2019.
  • 241 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Patton Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.